The Global RPMI Media Market Size is predicted to witness at a 7.29% CAGR during the forecast period for 2023-2031.
RPMI medium primarily cultivates mammalian cells in vitro, including cell lines and primary cells. It supplies the nutrients, growth agents, and minerals required for cell growth and proliferation. RPMI media is made consisting of a base medium that has been added with other components to provide a favorable environment for cell growth. The need for RPMI media is inextricably linked to advances in biological research and medication discovery.
The demand for RPMI medium for cell culture investigations is predicted to rise as the area of life sciences continues to expand, with new findings and therapeutic targets being uncovered. In addition, ongoing R&D initiatives to improve the composition and performance of RPMI media can boost market expansion.
However, during the pandemic, several research organizations and laboratories temporarily ceased non-essential research activity in order to prioritize employee safety and comply with lockdown procedures. This halting of non-essential research initiatives may have resulted in a temporary decrease in demand for RPMI media.
Recent Developments:
- In April 2022, Merck announced the acquisition of Lonza's MAST Platform, a leading automated bioreactor sampling system, to advance bioprocessing capabilities. The MAST platform is an automatic, aseptic bioreactor sampling system developed to increase bioprocessing capabilities for more efficient and cost-effective drug production. Bend, Oregon, is where the MAST platform was created.
Competitive Landscape:
Some of the RPMI Media Market Players are:
- Merck KGaA
- Thermo Fisher Scientific Inc
- Biological Industries
- Sigma-Aldrich
- Corning
- Biowest
- Hi-Media Laboratories
- Lifeline Cell Technology
- Lonza
- GE Healthcare Life Sciences
Market Segmentation:
The RPMI Media Market is segmented based on media form, media components, and application. Based on media form, the market is segmented as liquid and powder. The media components segment includes Without L-glutamine and With L-glutamine. By application, the market is segmented into scientific research and industrial production.
Based On Media Form, The Liquid Type Segment Is Accounted As A Noteworthy Contributor In The RPMI Media Market
The liquid type category is expected to hold a significant share of the global RPMI Media Market in 2022. This can be attributed to the benefits delivered by this medium, such as improved cell development and increased output. A form of RPMI media that contains water and dissolved nutrients is known as liquid media. It is used in laboratories to cultivate cells. There are two types of liquid media: sterile and non-sterile.
For researchers and laboratories, liquid RPMI media provide convenience and ease of usage. Liquid media's ready-to-use nature reduces the need for extensive media preparation stages, saving time and effort in the laboratory. This convenience element drives the need for liquid-type RPMI media, particularly in high-throughput applications or busy research contexts.
The Scientific Research Segment Witnessed Growth At A Rapid Rate
The scientific research segment is projected to grow at a rapid rate in the global RPMI Media Market. The use of RPMI medium in scientific research aids in the preservation of cell health and vitality. It's also employed in cell culture applications like growing and maintaining primary, stem, and tumor cells. Furthermore, the RPMI medium can be utilized to investigate cellular responses to various stimuli. As a result, it is a valuable resource for researchers all around the world.
Asia Pacific RPMI Media Market Holds A Significant Revenue Share In The Region
Asia Pacific RPMI Media Market is expected to register an exponential CAGR during the forecast period. The biopharmaceutical industry is expanding rapidly in the Asia Pacific area. China, Japan, South Korea, and India have invested significantly in biotechnology and pharmaceutical research and development.
The necessity for cell culture media in manufacturing biologics such as monoclonal antibodies, vaccines, and cell-based therapeutics drives the demand for RPMI media. North America is expected to grow significantly over the forecast period. The requirement for cell culture media in biopharmaceutical research and production, such as creating monoclonal antibodies, vaccines, and cell-based therapeutics, drives demand for RPMI media in North America.
RPMI Media Market Report Scope:
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 7.29 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Media Form, Media Components, And Application |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
Merck KGaA, Thermo Fisher Scientific Inc, Biological Industries, Sigma-Aldrich, Corning, Biowest, Hi-Media Laboratories, Lifeline Cell Technology, Lonza, and GE Healthcare Life Sciences. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
